http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0195799-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41d1be2928742cced67b67ea0c444301
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee1c19da359446fb5c4f0458a57b783d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-108
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
filingDate 1987-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_069e91d4bbf3ab6ba207aafd6fbebf01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e7a21bf3903003757474209534f1463
publicationDate 1989-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0195799-A
titleOfInvention Monoclonal antibody and method for immunochemical measurement
abstract PURPOSE:To measure human arginase, in human blood serum, etc., by synthesizing an antiarginase monoclonal antibody capable of binding to human arginase using an arginase of a mammal other than humans as an antigen. CONSTITUTION:A splenic cell obtained from a mouse immunized with purified or crude arginase is mixed and fused to a myelomatous cell of the same strain mouse in the presence of a cell fusion agent, such as polyethylene glycol, and then cultivated. The resultant hybridoma is selectively propagated using a hypoxanthine-aminopterin-thymidine culture medium, etc., to select cells capable of producing an antiarginase antibody. The obtained cells are subsequently propagated in an ordinary liquid culture medium, etc., to provide an antiarginase monoclonal antibody, which is then used to immunochemically measure a human arginase.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9628733-A1
priorityDate 1987-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450446348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159275911

Total number of triples: 33.